chlorpromazine has been researched along with amphotericin b in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (15.79) | 18.7374 |
1990's | 2 (10.53) | 18.2507 |
2000's | 6 (31.58) | 29.6817 |
2010's | 8 (42.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Farasati, NA; Huang, Y; Randhawa, P | 1 |
Im, KI; Jung, SY; Kim, JH; Kim, K; Kwon, D; Lee, YJ; Park, S; Shin, HJ; Song, KJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Baguley, BC; Ferguson, LR; Turner, PM | 1 |
Nugent, KM; Wood, NC | 1 |
Acosta, D; Wenzel, DG | 1 |
Gilbert, DL; Kim, MC; Martinez, JF; Trissel, LA | 1 |
Abe, S; Ishibashi, H; Oshima, H; Sato, Y; Takakura, N; Uchida, K; Yamaguchi, H | 1 |
ALLING, DW; UTZ, JP; WILLIAMS, TW | 1 |
Imamura, T; Katsu, T; Komagoe, K; Masuda, K; Mizushima, T | 1 |
Bellon, A; Beringue, V; Cronier, S; Laude, H; Peyrin, JM | 1 |
Galgóczy, L; Kovács, L; Ordögh, L; Papp, T; Vágvölgyi, C | 1 |
Alves, SH; Chassot, F; Loreto, ÉS; Rossato, L; Santurio, JM; Zanette, RA | 1 |
1 review(s) available for chlorpromazine and amphotericin b
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
18 other study(ies) available for chlorpromazine and amphotericin b
Article | Year |
---|---|
BK Virus replication in vitro: limited effect of drugs interfering with viral uptake and intracellular transport.
Topics: Antiviral Agents; BK Virus; Cell Line; Chloroquine; Humans; Microbial Sensitivity Tests; Molecular Structure; Nystatin; Virus Replication | 2007 |
Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
Topics: Amebiasis; Amebicides; Amphotericin B; Animals; Central Nervous System Protozoal Infections; Chlorpromazine; Female; In Vitro Techniques; Mice; Mice, Inbred BALB C; Naegleria fowleri; Parasitic Sensitivity Tests; Phosphorylcholine | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Stimulation of bacterial mutagenicity by inhibitors of mammalian cell multidrug resistance.
Topics: Aminoacridines; Amphotericin B; Antimalarials; Antineoplastic Agents; Calcium Channel Blockers; Chlorpromazine; Cyclosporine; Drug Resistance; Estrogen Antagonists; Frameshift Mutation; Mutagenicity Tests; Mutagens; Polysorbates; Reserpine; Salmonella typhimurium | 1991 |
Inhibitory effects of chlorpromazine on Candida species.
Topics: Amphotericin B; Candida; Chlorpromazine; Drug Interactions; Microbial Sensitivity Tests; Rifampin; Time Factors | 1985 |
Permeability of lysosomes and mitochondria in cultured rat heart muscle and endotheloid cells as affected by vitamin A, chlorpromazine, amphotericin B, and clofibrate.
Topics: Amphotericin B; Animals; Cells, Cultured; Chlorpromazine; Clofibrate; Endothelium; Feedback; Heart; Hydrocortisone; In Vitro Techniques; Lysosomes; Mitochondria, Muscle; Myocardium; Osmotic Fragility; Permeability; Rats; Staining and Labeling; Succinate Dehydrogenase; Time Factors; Vitamin A | 1973 |
Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
Topics: Amphotericin B; Analgesics, Opioid; Cefoperazone; Chemical Precipitation; Chlorpromazine; Drug Incompatibility; Piperidines; Remifentanil | 1997 |
A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis, Oral; Chlorpromazine; Disease Models, Animal; Female; Fluconazole; Immunocompromised Host; Mice; Mice, Inbred ICR; Prednisolone; Tetracycline; Virulence | 2003 |
REDUCING AMPHOTERICIN B REACTIONS. II. VOMITING.
Topics: Amphotericin B; Biomedical Research; Blastomycosis; Chlorpromazine; Coccidioidomycosis; Cryptococcosis; Drug Therapy; Fever; Histoplasmosis; Humans; Lactose; Nausea; Pentobarbital; Sporotrichosis; Toxicology; Vomiting | 1965 |
Simultaneous measurements of K+ and calcein release from liposomes and the determination of pore size formed in a membrane.
Topics: Alamethicin; Amphotericin B; Azepines; Celecoxib; Chlorpromazine; Fluoresceins; Gramicidin; Liposomes; Melitten; Membranes, Artificial; Nystatin; Permeability; Potassium; Pyrazoles; Sulfonamides | 2007 |
Prion strain- and species-dependent effects of antiprion molecules in primary neuronal cultures.
Topics: Amphotericin B; Animals; Cells, Cultured; Chlorpromazine; Congo Red; Cricetinae; Humans; Mice; Mice, Transgenic; Neurons; Prion Diseases; Prion Proteins; Prions; PrPC Proteins; PrPSc Proteins; Scrapie; Sheep; Species Specificity | 2007 |
In vitro activity of phenothiazines and their combinations with amphotericin B against Zygomycetes causing rhinocerebral zygomycosis.
Topics: Amphotericin B; Antifungal Agents; Chlorpromazine; Drug Synergism; Fungi; Humans; Meningoencephalitis; Microbial Sensitivity Tests; Rhinitis; Trifluoperazine; Zygomycosis | 2009 |
In vitro synergistic effects of chlorpromazine and sertraline in combination with amphotericin B against Cryptococcus neoformans var. grubii.
Topics: Amphotericin B; Antifungal Agents; Chlorpromazine; Cryptococcus neoformans; Drug Synergism; Humans; Microbial Sensitivity Tests; Sertraline | 2016 |